STERIS plc vs Johnson & Johnson
STE vs JNJ — side-by-side comparison from reported financials. STE leads 4, JNJ leads 6 of 10 comparable metrics.
STERIS plc
STE · Healthcare
$214.40+1.73%Strong
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | STE | JNJ |
|---|---|---|
| Price | $214.40 | $261.79 |
| Market cap | $20.9B | $631B |
| Revenue (TTM) | $6.04B | $97.9B |
| Revenue growth | +6.2% | +5.6% |
| Net margin | 13.3% | 21.5% |
| Free cash flow | $926M | $22.2B |
| Net cash (debt) | ($1.65B) | ($27.8B) |
| 1-year price return | -10.5% | +37.0% |
| P/E | 26.0 | 29.9 |
| P/E vs own history (cheap-side %) | 97% | 16% |
| Dividend yield | 1.18% | 2.00% |
| Return on equity | 11% | 26% |
| Altman Z-score | 4.34 | — |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 17,937 | 140,800 |
Full résumé-style profiles: STE CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.